Tapewire

Nasdaq · USD

GT

GOODYEAR TIRE & RUBBER CO /OH/

Export transactions ↓
Tapewire entity
753
SEC CIK
0000042582
Parsed reports
772

Last 12 months

Inside the activity.

1 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 22, 2022 Filed Apr 26, 2022 20:06 UTC
Madarang NathanielPresident, Asia Pacific
Tax withholdingCommon Stock 1,749 $13.21 $23,104.29
Disclosure

SEC source: 0001209191-22-025605 · doc4.xml · nonDerivative · entry 2

Madarang Nathaniel · CIK 0001850599 · President, Asia Pacific

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,741

F1 · kind: Shares of common stock withheld by the issuer for the payment of withholding taxes.

Read SEC document
April 22, 2022 Filed Apr 26, 2022 20:06 UTC
Madarang NathanielPresident, Asia Pacific
Exercise / conversionCommon Stock 3,886 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-025605 · doc4.xml · nonDerivative · entry 1

Madarang Nathaniel · CIK 0001850599 · President, Asia Pacific

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,490

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 17:13 UTC GrantRestricted Stock Units · Derivative 2,817 $14.20 $40,001.40
Disclosure

SEC source: 0001209191-22-022859 · doc4.xml · derivative · entry 1

Williams Thomas L · CIK 0001320730 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,566

Underlying: Common Stock · 2,817 shares

Expires not disclosed

F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan.

F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 17:05 UTC GrantRestricted Stock Units · Derivative 2,817 $14.20 $40,001.40
Disclosure

SEC source: 0001209191-22-022851 · doc4.xml · derivative · entry 1

STREETER STEPHANIE A · CIK 0001021762 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,038

Underlying: Common Stock · 2,817 shares

Expires not disclosed

F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan.

F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 17:10 UTC GrantRestricted Stock Units · Derivative 2,817 $14.20 $40,001.40
Disclosure

SEC source: 0001209191-22-022855 · doc4.xml · derivative · entry 1

Wessel Michael · CIK 0001346244 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,308

Underlying: Common Stock · 2,817 shares

Expires not disclosed

F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan.

F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 17:02 UTC
Siu Hera KDirector
GrantRestricted Stock Units · Derivative 2,817 $14.20 $40,001.40
Disclosure

SEC source: 0001209191-22-022849 · doc4.xml · derivative · entry 1

Siu Hera K · CIK 0001796462 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,014

Underlying: Common Stock · 2,817 shares

Expires not disclosed

F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan.

F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 16:51 UTC GrantRestricted Stock Units · Derivative 2,817 $14.20 $40,001.40
Disclosure

SEC source: 0001209191-22-022839 · doc4.xml · derivative · entry 1

MCCOLLOUGH W ALAN · CIK 0001209891 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,308

Underlying: Common Stock · 2,817 shares

Expires not disclosed

F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan.

F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 17:00 UTC GrantRestricted Stock Units · Derivative 2,817 $14.20 $40,001.40
Disclosure

SEC source: 0001209191-22-022847 · doc4.xml · derivative · entry 1

PALMORE RODERICK A · CIK 0001218964 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,259

Underlying: Common Stock · 2,817 shares

Expires not disclosed

F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan.

F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 16:54 UTC GrantRestricted Stock Units · Derivative 2,817 $14.20 $40,001.40
Disclosure

SEC source: 0001209191-22-022841 · doc4.xml · derivative · entry 1

MCGLADE JOHN E · CIK 0001265896 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,027

Underlying: Common Stock · 2,817 shares

Expires not disclosed

F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan.

F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 16:45 UTC GrantRestricted Stock Units · Derivative 2,817 $14.20 $40,001.40
Disclosure

SEC source: 0001209191-22-022835 · doc4.xml · derivative · entry 1

Lewis Karla R · CIK 0001256541 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,433

Underlying: Common Stock · 2,817 shares

Expires not disclosed

F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan.

F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 16:42 UTC GrantRestricted Stock Units · Derivative 2,817 $14.20 $40,001.40
Disclosure

SEC source: 0001209191-22-022834 · doc4.xml · derivative · entry 1

KOELLNER LAURETTE T · CIK 0001182054 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,321

Underlying: Common Stock · 2,817 shares

Expires not disclosed

F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan.

F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 16:32 UTC GrantRestricted Stock Units · Derivative 2,817 $14.20 $40,001.40
Disclosure

SEC source: 0001209191-22-022831 · doc4.xml · derivative · entry 1

Geissler Werner · CIK 0001402226 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,219

Underlying: Common Stock · 2,817 shares

Expires not disclosed

F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan.

F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 16:47 UTC GrantRestricted Stock Units · Derivative 572 $14.20 $8,122.40
Disclosure

SEC source: 0001209191-22-022836 · doc4.xml · derivative · entry 2

Mahendra-Rajah Prashanth · CIK 0001609983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 572

Underlying: Common Stock · 572 shares

Expires not disclosed

F4 · security: RSUs accrued, pursuant to an election by the reporting person, to the Retainer Deferral Account of the reporting person in accordance with the Plan.

F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F5 · balance_after: Total RSUs accrued to the Retainer Deferral Account of the reporting person as of the date of this statement.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 16:47 UTC GrantRestricted Stock Units · Derivative 2,817 $14.20 $40,001.40
Disclosure

SEC source: 0001209191-22-022836 · doc4.xml · derivative · entry 1

Mahendra-Rajah Prashanth · CIK 0001609983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,060

Underlying: Common Stock · 2,817 shares

Expires not disclosed

F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan.

F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 16:34 UTC GrantRestricted Stock Units · Derivative 2,817 $14.20 $40,001.40
Disclosure

SEC source: 0001209191-22-022832 · doc4.xml · derivative · entry 1

HELLMAN PETER S · CIK 0001107468 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,821

Underlying: Common Stock · 2,817 shares

Expires not disclosed

F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan.

F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 16:27 UTC GrantRestricted Stock Units · Derivative 2,817 $14.20 $40,001.40
Disclosure

SEC source: 0001209191-22-022830 · doc4.xml · derivative · entry 1

FIRESTONE JAMES A · CIK 0001207838 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,308

Underlying: Common Stock · 2,817 shares

Expires not disclosed

F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan.

F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:21 UTC
WELLS DARREN RExecutive VP and CFO
Grant2017 Plan Restricted Stock Units · Derivative 60,038 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-014728 · doc4.xml · derivative · entry 2

WELLS DARREN R · CIK 0001190977 · Executive VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,038

Underlying: Common Stock · 60,038 shares

Expires not disclosed

F2 · security: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 28, 2025.

F2 · derivative.exercise_price: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 28, 2025.

F2 · derivative.exercise_date: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 28, 2025.

F2 · derivative.expiration_date: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 28, 2025.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:21 UTC
WELLS DARREN RExecutive VP and CFO
Grant2017 Plan Performance Share Units · Derivative 40,025 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-014728 · doc4.xml · derivative · entry 1

WELLS DARREN R · CIK 0001190977 · Executive VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,025

Underlying: Common Stock · 40,025 shares

Expires not disclosed

F1 · security: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2025. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2024, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2024.

F1 · derivative.exercise_price: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2025. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2024, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2024.

F1 · derivative.exercise_date: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2025. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2024, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2024.

F1 · derivative.expiration_date: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2025. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2024, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2024.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:20 UTC
VanderLind GarySR VP & Chief Human Res. Ofcr.
Grant2017 Plan Restricted Stock Units · Derivative 21,304 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-014725 · doc4.xml · derivative · entry 2

VanderLind Gary · CIK 0001765321 · SR VP & Chief Human Res. Ofcr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,304

Underlying: Common Stock · 21,304 shares

Expires not disclosed

F2 · security: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 28, 2025.

F2 · derivative.exercise_price: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 28, 2025.

F2 · derivative.exercise_date: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 28, 2025.

F2 · derivative.expiration_date: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 28, 2025.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:20 UTC
VanderLind GarySR VP & Chief Human Res. Ofcr.
Grant2017 Plan Performance Share Units · Derivative 14,202 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-014725 · doc4.xml · derivative · entry 1

VanderLind Gary · CIK 0001765321 · SR VP & Chief Human Res. Ofcr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,202

Underlying: Common Stock · 14,202 shares

Expires not disclosed

F1 · security: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2025. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2024, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2024.

F1 · derivative.exercise_price: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2025. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2024, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2024.

F1 · derivative.exercise_date: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2025. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2024, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2024.

F1 · derivative.expiration_date: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2025. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2024, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2024.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:18 UTC
Scocos Evan MVice President and Controller
Grant2017 Plan Restricted Stock Units · Derivative 9,005 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-014720 · doc4.xml · derivative · entry 2

Scocos Evan M · CIK 0001674989 · Vice President and Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,005

Underlying: Common Stock · 9,005 shares

Expires not disclosed

F2 · security: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 28, 2025.

F2 · derivative.exercise_price: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 28, 2025.

F2 · derivative.exercise_date: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 28, 2025.

F2 · derivative.expiration_date: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 28, 2025.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:18 UTC
Scocos Evan MVice President and Controller
Grant2017 Plan Performance Share Units · Derivative 6,003 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-014720 · doc4.xml · derivative · entry 1

Scocos Evan M · CIK 0001674989 · Vice President and Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,003

Underlying: Common Stock · 6,003 shares

Expires not disclosed

F1 · security: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2025. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2024, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2024.

F1 · derivative.exercise_price: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2025. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2024, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2024.

F1 · derivative.exercise_date: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2025. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2024, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2024.

F1 · derivative.expiration_date: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2025. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2024, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2024.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:16 UTC
Phillips David EmmittSr VP and General Counsel
Grant2017 Plan Restricted Stock Units · Derivative 27,114 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-014713 · doc4.xml · derivative · entry 2

Phillips David Emmitt · CIK 0001777552 · Sr VP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,114

Underlying: Common Stock · 27,114 shares

Expires not disclosed

F2 · security: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 28, 2025.

F2 · derivative.exercise_price: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 28, 2025.

F2 · derivative.exercise_date: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 28, 2025.

F2 · derivative.expiration_date: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 28, 2025.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:16 UTC
Phillips David EmmittSr VP and General Counsel
Grant2017 Plan Performance Share Units · Derivative 18,076 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-014713 · doc4.xml · derivative · entry 1

Phillips David Emmitt · CIK 0001777552 · Sr VP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,076

Underlying: Common Stock · 18,076 shares

Expires not disclosed

F1 · security: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2025. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2024, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2024.

F1 · derivative.exercise_price: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2025. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2024, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2024.

F1 · derivative.exercise_date: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2025. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2024, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2024.

F1 · derivative.expiration_date: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2025. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2024, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2024.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:15 UTC
Patterson Ryan GSr VP, CO & Int Ofcr, Americas
Grant2017 Plan Restricted Stock Units · Derivative 30,987 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-014711 · doc4.xml · derivative · entry 2

Patterson Ryan G · CIK 0001717110 · Sr VP, CO & Int Ofcr, Americas

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,987

Underlying: Common Stock · 30,987 shares

Expires not disclosed

F2 · security: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 28, 2025.

F2 · derivative.exercise_price: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 28, 2025.

F2 · derivative.exercise_date: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 28, 2025.

F2 · derivative.expiration_date: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 28, 2025.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:15 UTC
Patterson Ryan GSr VP, CO & Int Ofcr, Americas
Grant2017 Plan Performance Share Units · Derivative 20,658 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-014711 · doc4.xml · derivative · entry 1

Patterson Ryan G · CIK 0001717110 · Sr VP, CO & Int Ofcr, Americas

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,658

Underlying: Common Stock · 20,658 shares

Expires not disclosed

F1 · security: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2025. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2024, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2024.

F1 · derivative.exercise_price: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2025. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2024, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2024.

F1 · derivative.exercise_date: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2025. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2024, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2024.

F1 · derivative.expiration_date: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2025. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2024, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2024.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:12 UTC
McClellan Stephen RPresident, Americas
Grant2017 Plan Restricted Stock Units · Derivative 54,228 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-014703 · doc4.xml · derivative · entry 2

McClellan Stephen R · CIK 0001447779 · President, Americas

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,228

Underlying: Common Stock · 54,228 shares

Expires not disclosed

F2 · security: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 28, 2025.

F2 · derivative.exercise_price: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 28, 2025.

F2 · derivative.exercise_date: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 28, 2025.

F2 · derivative.expiration_date: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 28, 2025.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:12 UTC
McClellan Stephen RPresident, Americas
Grant2017 Plan Performance Share Units · Derivative 36,152 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-014703 · doc4.xml · derivative · entry 1

McClellan Stephen R · CIK 0001447779 · President, Americas

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,152

Underlying: Common Stock · 36,152 shares

Expires not disclosed

F1 · security: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2025. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2024, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2024.

F1 · derivative.exercise_price: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2025. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2024, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2024.

F1 · derivative.exercise_date: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2025. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2024, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2024.

F1 · derivative.expiration_date: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2025. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2024, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2024.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:11 UTC
Madarang NathanielPresident, Asia Pacific
Grant2017 Plan Restricted Stock Units · Derivative 19,367 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-014697 · doc4.xml · derivative · entry 2

Madarang Nathaniel · CIK 0001850599 · President, Asia Pacific

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,367

Underlying: Common Stock · 19,367 shares

Expires not disclosed

F2 · security: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 28, 2025.

F2 · derivative.exercise_price: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 28, 2025.

F2 · derivative.exercise_date: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 28, 2025.

F2 · derivative.expiration_date: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 28, 2025.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:11 UTC
Madarang NathanielPresident, Asia Pacific
Grant2017 Plan Performance Share Units · Derivative 12,911 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-014697 · doc4.xml · derivative · entry 1

Madarang Nathaniel · CIK 0001850599 · President, Asia Pacific

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,911

Underlying: Common Stock · 12,911 shares

Expires not disclosed

F1 · security: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2025. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2024, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2024.

F1 · derivative.exercise_price: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2025. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2024, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2024.

F1 · derivative.exercise_date: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2025. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2024, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2024.

F1 · derivative.expiration_date: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2025. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2024, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2024.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:09 UTC
KRAMER RICHARD JDirector · Chairman of the Bd, CEO & Pres
Grant2017 Plan Restricted Stock Units · Derivative 206,262 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-014689 · doc4.xml · derivative · entry 2

KRAMER RICHARD J · CIK 0001201067 · Director · Chairman of the Bd, CEO & Pres

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 206,262

Underlying: Common Stock · 206,262 shares

Expires not disclosed

F2 · security: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 28, 2025.

F2 · derivative.exercise_price: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 28, 2025.

F2 · derivative.exercise_date: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 28, 2025.

F2 · derivative.expiration_date: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 28, 2025.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:09 UTC
KRAMER RICHARD JDirector · Chairman of the Bd, CEO & Pres
Grant2017 Plan Performance Share Units · Derivative 137,508 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-014689 · doc4.xml · derivative · entry 1

KRAMER RICHARD J · CIK 0001201067 · Director · Chairman of the Bd, CEO & Pres

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 137,508

Underlying: Common Stock · 137,508 shares

Expires not disclosed

F1 · security: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2025. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2024, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2024.

F1 · derivative.exercise_price: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2025. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2024, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2024.

F1 · derivative.exercise_date: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2025. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2024, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2024.

F1 · derivative.expiration_date: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2025. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2024, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2024.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:06 UTC
Helsel Christopher PSr VP Glbl Ops Chief Tech Ofcr
Grant2017 Plan Restricted Stock Units · Derivative 22,756 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-014677 · doc4.xml · derivative · entry 2

Helsel Christopher P · CIK 0001763728 · Sr VP Glbl Ops Chief Tech Ofcr

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,756

Underlying: Common Stock · 22,756 shares

Expires not disclosed

F2 · security: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 28, 2025.

F2 · derivative.exercise_price: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 28, 2025.

F2 · derivative.exercise_date: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 28, 2025.

F2 · derivative.expiration_date: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 28, 2025.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:06 UTC
Helsel Christopher PSr VP Glbl Ops Chief Tech Ofcr
Grant2017 Plan Performance Share Units · Derivative 15,170 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-014677 · doc4.xml · derivative · entry 1

Helsel Christopher P · CIK 0001763728 · Sr VP Glbl Ops Chief Tech Ofcr

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,170

Underlying: Common Stock · 15,170 shares

Expires not disclosed

F1 · security: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2025. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2024, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2024.

F1 · derivative.exercise_price: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2025. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2024, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2024.

F1 · derivative.exercise_date: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2025. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2024, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2024.

F1 · derivative.expiration_date: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2025. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2024, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2024.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:04 UTC
Duda Laura PSR VP & Chief Comm. Officer
Grant2017 Plan Restricted Stock Units · Derivative 10,652 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-014668 · doc4.xml · derivative · entry 2

Duda Laura P · CIK 0001763990 · SR VP & Chief Comm. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,652

Underlying: Common Stock · 10,652 shares

Expires not disclosed

F2 · security: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 28, 2025.

F2 · derivative.exercise_price: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 28, 2025.

F2 · derivative.exercise_date: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 28, 2025.

F2 · derivative.expiration_date: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 28, 2025.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:04 UTC
Duda Laura PSR VP & Chief Comm. Officer
Grant2017 Plan Performance Share Units · Derivative 7,101 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-014668 · doc4.xml · derivative · entry 1

Duda Laura P · CIK 0001763990 · SR VP & Chief Comm. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,101

Underlying: Common Stock · 7,101 shares

Expires not disclosed

F1 · security: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2025. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2024, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2024.

F1 · derivative.exercise_price: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2025. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2024, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2024.

F1 · derivative.exercise_date: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2025. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2024, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2024.

F1 · derivative.expiration_date: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2025. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2024, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2024.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:03 UTC
Delaney Christopher RPresident, EMEA
Grant2017 Plan Restricted Stock Units · Derivative 54,228 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-014666 · doc4.xml · derivative · entry 2

Delaney Christopher R · CIK 0001663064 · President, EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,228

Underlying: Common Stock · 54,228 shares

Expires not disclosed

F2 · security: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 28, 2025.

F2 · derivative.exercise_price: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 28, 2025.

F2 · derivative.exercise_date: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 28, 2025.

F2 · derivative.expiration_date: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 28, 2025.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:03 UTC
Delaney Christopher RPresident, EMEA
Grant2017 Plan Performance Share Units · Derivative 36,152 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-014666 · doc4.xml · derivative · entry 1

Delaney Christopher R · CIK 0001663064 · President, EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,152

Underlying: Common Stock · 36,152 shares

Expires not disclosed

F1 · security: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2025. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2024, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2024.

F1 · derivative.exercise_price: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2025. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2024, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2024.

F1 · derivative.exercise_date: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2025. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2024, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2024.

F1 · derivative.expiration_date: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2025. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2024, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2024.

Read SEC document
February 25, 2022 Filed Mar 1, 2022 21:25 UTC
WELLS DARREN RExecutive VP and CFO
Exercise / conversion2017 Plan Restricted Stock Units · Derivative 45,669 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-014013 · doc4.xml · derivative · entry 3

WELLS DARREN R · CIK 0001190977 · Executive VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 45,669 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: This Form 4 reports the vesting and conversion of Restricted Stock Units ("RSUs") granted in February, 2019.

F2 · derivative.exercise_price: This Form 4 reports the vesting and conversion of Restricted Stock Units ("RSUs") granted in February, 2019.

F2 · derivative.exercise_date: This Form 4 reports the vesting and conversion of Restricted Stock Units ("RSUs") granted in February, 2019.

F2 · derivative.expiration_date: This Form 4 reports the vesting and conversion of Restricted Stock Units ("RSUs") granted in February, 2019.

Read SEC document
February 25, 2022 Filed Mar 1, 2022 21:25 UTC
WELLS DARREN RExecutive VP and CFO
Tax withholdingCommon Stock 20,711 $15.51 $321,227.61
Disclosure

SEC source: 0001209191-22-014013 · doc4.xml · nonDerivative · entry 2

WELLS DARREN R · CIK 0001190977 · Executive VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,919

F1 · kind: Shares of common stock withheld by the issuer for the payment of withholding taxes.

Read SEC document
February 25, 2022 Filed Mar 1, 2022 21:25 UTC
WELLS DARREN RExecutive VP and CFO
Exercise / conversionCommon Stock 45,669 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-014013 · doc4.xml · nonDerivative · entry 1

WELLS DARREN R · CIK 0001190977 · Executive VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,630

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 25, 2022 Filed Mar 1, 2022 21:23 UTC
VanderLind GarySR VP & Chief Human Res. Ofcr.
Exercise / conversion2017 Plan Restricted Stock Units · Derivative 11,023 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-014004 · doc4.xml · derivative · entry 3

VanderLind Gary · CIK 0001765321 · SR VP & Chief Human Res. Ofcr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,023 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: This Form 4 reports the vesting and conversion of Restricted Stock Units ("RSUs") granted in February, 2019.

F2 · derivative.exercise_price: This Form 4 reports the vesting and conversion of Restricted Stock Units ("RSUs") granted in February, 2019.

F2 · derivative.exercise_date: This Form 4 reports the vesting and conversion of Restricted Stock Units ("RSUs") granted in February, 2019.

F2 · derivative.expiration_date: This Form 4 reports the vesting and conversion of Restricted Stock Units ("RSUs") granted in February, 2019.

Read SEC document
February 25, 2022 Filed Mar 1, 2022 21:23 UTC
VanderLind GarySR VP & Chief Human Res. Ofcr.
Tax withholdingCommon Stock 4,999 $15.51 $77,534.49
Disclosure

SEC source: 0001209191-22-014004 · doc4.xml · nonDerivative · entry 2

VanderLind Gary · CIK 0001765321 · SR VP & Chief Human Res. Ofcr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,206

F1 · kind: Shares of common stock withheld by the issuer for the payment of withholding taxes.

Read SEC document
February 25, 2022 Filed Mar 1, 2022 21:23 UTC
VanderLind GarySR VP & Chief Human Res. Ofcr.
Exercise / conversionCommon Stock 11,023 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-014004 · doc4.xml · nonDerivative · entry 1

VanderLind Gary · CIK 0001765321 · SR VP & Chief Human Res. Ofcr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,205

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 25, 2022 Filed Mar 1, 2022 21:21 UTC
Scocos Evan MVice President and Controller
Exercise / conversion2017 Plan Restricted Stock Units · Derivative 5,511 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-013995 · doc4.xml · derivative · entry 4

Scocos Evan M · CIK 0001674989 · Vice President and Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,511 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: This Form 4 reports the vesting and conversion of Restricted Stock Units ("RSUs") granted in February, 2019.

F3 · derivative.exercise_price: This Form 4 reports the vesting and conversion of Restricted Stock Units ("RSUs") granted in February, 2019.

F3 · derivative.exercise_date: This Form 4 reports the vesting and conversion of Restricted Stock Units ("RSUs") granted in February, 2019.

F3 · derivative.expiration_date: This Form 4 reports the vesting and conversion of Restricted Stock Units ("RSUs") granted in February, 2019.

Read SEC document
February 25, 2022 Filed Mar 1, 2022 21:21 UTC
Scocos Evan MVice President and Controller
Tax withholdingCommon Stock 1,673 $15.51 $25,948.23
Disclosure

SEC source: 0001209191-22-013995 · doc4.xml · nonDerivative · entry 2

Scocos Evan M · CIK 0001674989 · Vice President and Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,726

F1 · kind: Shares of common stock withheld by the issuer for the payment of withholding taxes.

Read SEC document
February 25, 2022 Filed Mar 1, 2022 21:21 UTC
Scocos Evan MVice President and Controller
Exercise / conversionCommon Stock 5,511 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-013995 · doc4.xml · nonDerivative · entry 1

Scocos Evan M · CIK 0001674989 · Vice President and Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,399

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 25, 2022 Filed Mar 1, 2022 21:18 UTC
Phillips David EmmittSr VP and General Counsel
Exercise / conversion2017 Plan Restricted Stock Units · Derivative 1,837 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-013991 · doc4.xml · derivative · entry 3

Phillips David Emmitt · CIK 0001777552 · Sr VP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,837 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: This Form 4 reports the vesting and conversion of Restricted Stock Units ("RSUs") granted in February, 2019.

F2 · derivative.exercise_price: This Form 4 reports the vesting and conversion of Restricted Stock Units ("RSUs") granted in February, 2019.

F2 · derivative.exercise_date: This Form 4 reports the vesting and conversion of Restricted Stock Units ("RSUs") granted in February, 2019.

F2 · derivative.expiration_date: This Form 4 reports the vesting and conversion of Restricted Stock Units ("RSUs") granted in February, 2019.

Read SEC document
February 25, 2022 Filed Mar 1, 2022 21:18 UTC
Phillips David EmmittSr VP and General Counsel
Tax withholdingCommon Stock 834 $15.51 $12,935.34
Disclosure

SEC source: 0001209191-22-013991 · doc4.xml · nonDerivative · entry 2

Phillips David Emmitt · CIK 0001777552 · Sr VP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,118

F1 · kind: Shares of common stock withheld by the issuer for the payment of withholding taxes.

Read SEC document
February 25, 2022 Filed Mar 1, 2022 21:18 UTC
Phillips David EmmittSr VP and General Counsel
Exercise / conversionCommon Stock 1,837 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-013991 · doc4.xml · nonDerivative · entry 1

Phillips David Emmitt · CIK 0001777552 · Sr VP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,952

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.